Ocuphire Pharma Investor Updates slide image

Ocuphire Pharma Investor Updates

P 20 Secondary Endpoint: Mean Pupil Diameter Over Time Achieved Pupil Size ~2mm In Nyxol+LDP Consistent With 3-line Improvement In Near Vision 5.0 4.0 Mean Pupil Diameter (mm) 3.0 ≥2.0 1.0 4.8 4.4 4.3 4.2 Daily Evening Nyxol Dosing 12 hr minimum interval to Time 0 *** 4.5 3.1 Baseline 4.3 0 3.2 *** *** *** 4.5 3.2 3.0 N 2.4 *** T *** ** HH 4.4 1 3.2 2.5 2.1 Best Eye Mean Pupil Diameter *** *** ** H КН 4.3 3.4 2.7 2.3 *** *** 3.3 *** 4.4 3 3.1 2.5 *** T *** *** 4.4 2 -LDP (n=31) Time (Hours) -Placebo (n=43) Nyxol+LDP (n=43)-Nyxol (n=30) Source: VEGA-1 TLR Table 14.2.12.1 Observed Values and Change from Baseline in Photopic Pupil Diameter by Time Point (PP Population) 3.3 4 3.3 2.7 *** 4.6 Statistics Compared to Nyxol+LDP arm *p<0.05 **p<0.01 ***p<0.0001 5 *** 3.6 ** 6 3.3 2.9 Ocuphire PHARMA
View entire presentation